MiMedx集团 MDXG 深 沪
等待开盘 11-06 09:30:00 美东时间
7.865
+0.175
+2.28%
华盛通- 最 高7.93
- 今 开7.67
- 成交量 46.48万股
- 最 低 7.61
- 昨 收 7.69
- 总市值 11.64亿
- 52周最高 10.14
- 市盈率 静 27.64
- 换手率 0.31%
- 52周最低 5.79
- 委 比 32.25%
- 总股本 1.48亿
- 历史最高 18.25
- 量 比 0.27
- 振 幅 4.16%
- 历史最低 0.83
- 每 手 1
- 风险率 1.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule
MiMedx Group, Inc. ("MIMEDX") has responded to CMS's release of the CY 2026 Physician Fee Schedule final rule, which aims to address fraud, waste, and abuse in the Medicare reimbursement system for skin substitutes. Joseph H. Capper, MIMEDX Chief Executive Officer, stated that while the final rule aligns with earlier proposed changes, it provides a significant opportunity for MIMEDX to leverage its competitive advantages. The company believes the...
11-03 14:15
MiMedx Group shares are trading higher after the company reported Q3 results above estimates.
MiMedx Group shares are trading higher after the company reported Q3 results ab...
10-30 19:42
Earnings Scheduled For October 29, 2025
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
MIMEDX Announces Launch of EPIXPRESS®
MiMedx Group announced the launch of EPIXPRESS, a new advanced wound care solution. This lyophilized placental allograft features a fenestrated design to enhance fluid movement, improving treatment for hard-to-heal wounds such as diabetic foot ulcers and venous leg ulcers. As part of the company’s AWC portfolio, EPIXPRESS continues MIMEDX’s commitment to innovative, market-driven solutions for wound management.
10-06 13:28
MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall
MiMedx Group announced its participation in the SAWC Fall meeting in Las Vegas, showcasing its advanced wound care portfolio at booth 511. The company will host a sponsored lunch symposium titled "Change is Inevitable: Mastering the Art of Wound Healing in an Evolving Landscape" on September 4, featuring experts Paul Kim, Nicolas Mouawad, and Scott Boynton. Additionally, six clinical posters will be presented, focusing on wound care innovations. ...
09-03 12:00
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne
MDxHealth在2025年第二季度实现了20%的收入增长，达到2660万美元，并通过收购Bio-Techne的ExoDx业务，进一步扩展其前列腺癌液基诊断能力，预计将在2025年第四季度提升调整后EBITDA。
08-05 20:01
What to Expect from Ardelyx's Earnings
Ardelyx (NASDAQ:ARDX) is gearing up to announce its quarterly earnings on Monda...
08-02 04:01
Cantor Fitzgerald Maintains Overweight on MiMedx Group, Raises Price Target to $12
Cantor Fitzgerald analyst Ross Osborn maintains MiMedx Group (NASDAQ:MDXG) with a Overweight and raises the price target from $11 to $12.
07-31 20:54
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers OSR Holdings (NASDAQ:OSRH) stock rose 21.4% to $1.05 during Wednesday'...
07-31 05:06
MiMedx Group And Vaporox Collaborate To Co-Promote And Co-Market Their Wound Care Offerings
MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") and Vaporox, Inc. ("Vaporox") today jointly announced a collaboration, whereby the companies will co-promote and co-market their wound care offerings. As part
07-30 20:04
